Rituximab in CD20 positive multiple myeloma

被引：0
|
作者：
J M Bergua
C Cabrera
E G Arteta
J Prieto
机构：
[1] Servicio de Hematología,
[2] Hospital San Pedro de Alcántara,undefined
[3] Avda. Pablo Naranjo s/n,undefined
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1082 / 1083
页数：1
相关论文
共 50 条
  • [31] Structural basis for recognition of CD20 by therapeutic antibody rituximab
    Du, Jiamu
    Wang, Hao
    Zhong, Chen
    Peng, Baozhen
    Zhang, Meilan
    Li, Bohua
    Huo, Sheng
    Guo, Yajun
    Ding, Jianping
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (20) : 15073 - 15080
  • [32] High, stable and homogenous CD20 expression for efficient rituximab-induced elimination of CD20+ alloreactive donor T cells in the novel CD20/Rituximab 'suicide' system
    van Meerten, T
    Claessen, MJ
    Hagenbeek, A
    Ebeling, S
    BLOOD, 2004, 104 (11) : 485A - 485A
  • [33] 抗CD20单克隆抗体—Rituximab
    赵江宁
    朱雅丽
    白血病淋巴瘤., 2004, (02) : 123 - 125
  • [34] Efficacy and tolerability of rituximab-based chemotherapy in CD20 positive non-Hodgkin lymphoma
    Cedrych, I.
    Polakiewicz-Gilowska, A.
    Nowara, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 246 - 246
  • [35] Restoration of rituximab sensitivity in CD20 negative B-Cell lymphoma, cells; Epigenetic change of CD20 expression after treatment of rituximab.
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tornoki
    BLOOD, 2006, 108 (11) : 155B - 155B
  • [36] Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy
    Korte, W
    Jost, C
    Cogliatti, S
    Hess, U
    Cerny, T
    ANNALS OF ONCOLOGY, 1999, 10 (10) : 1249 - 1250
  • [37] Rituximab: A monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris
    El Tal, Abdul Kader
    Posner, Marshall R.
    Spigelman, Zachary
    Ahmed, A. Razzaque
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (03) : 449 - 459
  • [38] CD20 positive mycosis fungoides: a case report
    Sen, Filiz
    Kang, Steven
    Cangiarella, Joan
    Kamino, Hideko
    Hymes, Kenneth
    JOURNAL OF CUTANEOUS PATHOLOGY, 2008, 35 (04) : 398 - 403
  • [39] Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: A pilot series
    Chevallier, Patrice
    Pigneux, Arnaud
    Robillard, Nelly
    Ayari, Sameh
    Guillaume, Thierry
    Delaunay, Jacques
    Eveillard, Marion
    Dumas, Pierre-Yves
    Lippert, Eric
    Mohty, Mohamad
    Leguay, Thibaut
    LEUKEMIA RESEARCH, 2012, 36 (03) : 311 - 315
  • [40] Phase II individualized pharmacokinetic (PK) dosing of rituximab for patients with CD20 positive lymphoproliferative disorders.
    Lynch, JW
    Pusateri, A
    Balasubramanian, L
    Mendenhall, N
    Grow, B
    BLOOD, 2001, 98 (11) : 244B - 244B
12345